BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 733979)

  • 1. The effect of inhibition of prostaglandin synthesis on plasma renin activity and blood pressure in essential hypertension.
    Ylitalo P; Pitkäjärvi T; Metsä-Ketelä T; Vapaatalo H
    Prostaglandins Med; 1978 Dec; 1(6):479-88. PubMed ID: 733979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of a beta 1-blocking agent, atenolol, on blood pressure, plasma renin activity and prostaglandin F2 alpha excretion in patients with essential hypertension.
    Pitkäjärvi T; Ylitalo P; Metsä-Ketelä T; Vapaatalo H
    Acta Med Scand; 1979; 206(1-2):107-13. PubMed ID: 484251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of prostaglandin synthesis by indomethacin interacts with the antihypertensive effect of atenolol.
    Ylitalo P; Pitkäjärvi T; Pyykönen ML; Nurmi AK; Seppälä E; Vapaatalo H
    Clin Pharmacol Ther; 1985 Oct; 38(4):443-9. PubMed ID: 3899459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of plasma renin activity by indomethacin in man.
    Frölich JC; Hollifield JW; Dormois JC; Frölich BL; Seyberth H; Michelakis AM; Oates JA
    Circ Res; 1976 Sep; 39(3):447-52. PubMed ID: 821675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of free arachidonic acid by furosemide in man as the cause of prostaglandin and renin release.
    Weber PC; Scherer B; Larsson C
    Eur J Pharmacol; 1977 Feb; 41(3):329-32. PubMed ID: 837974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prostaglandin synthesis inhibition on blood pressure and humoral factors in exercising, sodium-deplete normal man.
    Staessen J; Fagard R; Lijnen P; Moerman E; De Schaepdryver A; Amery A
    J Hypertens; 1983 Aug; 1(2):123-30. PubMed ID: 6397516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of indomethacin on the natriuretic and renin-stimulating effect of bumetanide in essential hypertension.
    Pedrinelli R; Magagna A; Arzilli F; Sassano P; Salvetti A
    Clin Pharmacol Ther; 1980 Dec; 28(6):722-31. PubMed ID: 7002429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of indomethacin on plasma renin activity, plasma aldosterone concentration, urinary prostaglandin E excretion and blood pressure in patients with essential hypertension.
    Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Imai Y; Saito K; Sakurai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1979 May; 128(1):31-7. PubMed ID: 452004
    [No Abstract]   [Full Text] [Related]  

  • 9. Dependence of plasma renin activity on protaglandin excretion in essential hypertension.
    Ylitalo P; Vapaatalo H; Metsä-Ketelä T; Pitkäjärvi T
    Acta Physiol Scand; 1978 Jan; 102(1):120-2. PubMed ID: 626085
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduction by indomethacin of furosemide effects in the rabbit.
    Oliw E; Kövér G; Larsson C; Anggård E
    Eur J Pharmacol; 1976 Jul; 38(1):95-100. PubMed ID: 954837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of indomethacin blockade of prostaglandin synthesis on blood pressure of normal rabbits and rabbits with renovascular hypertension.
    Romero JC; Strong CG
    Circ Res; 1977 Jan; 40(1):35-41. PubMed ID: 830437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of plasma renin activity by inhibition of the fatty acid cyclooxygenase in human subjects: independence of sodium retention.
    Frölich JC; Hollifield JW; Michelakis AM; Vesper BS; Wilson JP; Shand DG; Seyberth HJ; Frölich WH; Oates JA
    Circ Res; 1979 Jun; 44(6):781-7. PubMed ID: 218749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin excretion after furosemide in normal and low-renin essential hypertension.
    Scherer B; Witzgall H; Weber PC
    Klin Wochenschr; 1984 Aug; 62(16):777-82. PubMed ID: 6384651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of angiotensin II receptor blockade with losartan on systemic blood pressure and renal and extrarenal prostaglandin synthesis in women with essential hypertension.
    Smith MC; Barrows S; Meibohm A; Shahinfar S; Simpson RL; Weigel K; Dunn MJ
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1177-83. PubMed ID: 8998251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma catecholamines in man are not influenced by the inhibition of prostaglandin synthesis.
    Rubin P; Blaschke T
    Prostaglandins; 1979 Apr; 17(4):581-5. PubMed ID: 461821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of prostaglandins in renin suppression during acute potassium loading.
    Kirchner KA
    Am J Physiol; 1985 Mar; 248(3 Pt 2):F360-5. PubMed ID: 3883811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active and acid-activable inactive renin during inhibition by indomethacin of prostaglandin synthesis in sodium-replete man.
    Lijnen P; Staessen J; Fagard R; Groeseneken D; M'Buyamba-Kabangu JR; Grauwels R; Amery A
    Eur J Clin Invest; 1985 Jun; 15(3):141-5. PubMed ID: 3926508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition.
    Silberbauer K; Stanek B; Templ H
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):87S-93S. PubMed ID: 6753910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of indomethacin on plasma renin activity and urinary aldosterone of patients with essential hypertension.
    Pedrinelli R; Arzilli F; Cavasinni L; Poli L; Sassano P; Salvetti A
    J Endocrinol Invest; 1978 Oct; 1(4):315-20. PubMed ID: 756881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects.
    Ichihara A; Suzuki H; Saruta T
    J Lab Clin Med; 1993 Oct; 122(4):432-40. PubMed ID: 8228558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.